These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 2018359)
1. Erbulozole (P.I.N.N.) (R 55 104) encapsulated into cyclodextrins: has it a combined antitumoral and radioprotective potential? Distelmans W; Van Ginckel R; Vanherck W; Willebrords R; Wouters L; De Brabander M; Mesens J Anticancer Res; 1991; 11(1):253-6. PubMed ID: 2018359 [TBL] [Abstract][Full Text] [Related]
2. Influence of the synthetic microtubule inhibitor erbulozole (P.I.N.N.) (R 55 104), a new tubulozole congener, and gamma irradiation on murine tumors in vivo. Distelmans W; Van Ginckel R; Vanherck W; Willebrords R; De Brabander M; Wouters L; Heeres J Eur J Cancer Clin Oncol; 1989 Oct; 25(10):1499-504. PubMed ID: 2591442 [TBL] [Abstract][Full Text] [Related]
4. Interaction between the microtubule inhibitor tubulozole and gamma-irradiation in murine tumors in vivo. Distelmans W; Van Ginckel R; Vanherck W; Willebrords R; De Brabander M; Wouters L; Van den Winkel P; De Backer G Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):177-82. PubMed ID: 2912940 [TBL] [Abstract][Full Text] [Related]
5. [Effect of combined use of radiation and twice intratumor administration of OK-432 at one week intervals against a murine fibrosarcoma (NFSA)]. Mukai M; Ando K; Koike S Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):631-5. PubMed ID: 3355184 [TBL] [Abstract][Full Text] [Related]
6. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. Kishi K; Petersen S; Petersen C; Hunter N; Mason K; Masferrer JL; Tofilon PJ; Milas L Cancer Res; 2000 Mar; 60(5):1326-31. PubMed ID: 10728694 [TBL] [Abstract][Full Text] [Related]
7. Dependence of indomethacin-induced potentiation of murine tumor radioresponse on tumor host immunocompetence. Milas L; Furuta Y; Hunter N; Nishiguchi I; Runkel S Cancer Res; 1990 Aug; 50(15):4473-7. PubMed ID: 2369725 [TBL] [Abstract][Full Text] [Related]
8. Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy. Urano M; Kuroda M; Reynolds R; Oberley TD; St Clair DK Cancer Res; 1995 Jun; 55(12):2490-3. PubMed ID: 7780953 [TBL] [Abstract][Full Text] [Related]
9. Toxicity, radiation sensitivity modification, and combined drug effects of ascorbic acid with misonidazole in vivo on FSaII murine fibrosarcomas. Okunieff P; Suit HD J Natl Cancer Inst; 1987 Aug; 79(2):377-81. PubMed ID: 3474467 [TBL] [Abstract][Full Text] [Related]
10. Radiation therapy to a primary tumor accelerates metastatic growth in mice. Camphausen K; Moses MA; Beecken WD; Khan MK; Folkman J; O'Reilly MS Cancer Res; 2001 Mar; 61(5):2207-11. PubMed ID: 11280788 [TBL] [Abstract][Full Text] [Related]
11. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance. Milas L; McBride WH; Hunter N; Ito H Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014 [TBL] [Abstract][Full Text] [Related]
12. Increase in radioresponse of murine tumors by treatment with indomethacin. Furuta Y; Hunter N; Barkley T; Hall E; Milas L Cancer Res; 1988 Jun; 48(11):3008-13. PubMed ID: 3365690 [TBL] [Abstract][Full Text] [Related]
13. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice. Milas L; Hunter N; Reid BO; Thames HD Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response. Griffin RJ; Williams BW; Wild R; Cherrington JM; Park H; Song CW Cancer Res; 2002 Mar; 62(6):1702-6. PubMed ID: 11912143 [TBL] [Abstract][Full Text] [Related]
15. Modification of gamma radiation induced response of peritoneal macrophages and splenocytes by Hippophae rhamnoides (RH-3) in mice. Prakash H; Bala M; Ali A; Goel HC J Pharm Pharmacol; 2005 Aug; 57(8):1065-72. PubMed ID: 16102264 [TBL] [Abstract][Full Text] [Related]
16. Effect of X-rays and cyclophosphamide on solid tumors and naturally occurring metastases in mice. Chu AM; Fowler JF Cancer Res; 1982 May; 42(5):1943-9. PubMed ID: 7066905 [TBL] [Abstract][Full Text] [Related]
17. [Combination therapy of local administration of OK-432 and radiation on a murine fibrosarcoma (NFSa)--combination effect and histological examination]. Mukai M; Ando K; Koike S; Ishikawa T; Ryu M; Nagashima T; Nagao K; Isono K Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):556-62. PubMed ID: 3954378 [TBL] [Abstract][Full Text] [Related]
18. Radioprotective effects of various cytokines in peripheral blood mononuclear cells and C3H mice. Kim JY; Oh SJ; Park HK; Yoon JS; Kim ES; Kim ES; Kim CS; Lee YY; Kim BK Oncol Rep; 2005 Jun; 13(6):1177-83. PubMed ID: 15870940 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the radioprotective effect of Liv 52 in mice. Jagetia GC; Ganapathi NG; Venkatesh P; Rao N; Baliga MS Environ Mol Mutagen; 2006 Aug; 47(7):490-502. PubMed ID: 16758471 [TBL] [Abstract][Full Text] [Related]
20. The prostaglandin E1 analog, misoprostol, a normal tissue protector, does not protect four murine tumors in vivo from radiation injury. Hanson WR; Zhen W; Geng L; Hunter N; Milas L Radiat Res; 1995 Jun; 142(3):281-7. PubMed ID: 7761578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]